ANAKINRA

Approval Year

Substance Class	Protein
Protein Type	CYTOKINE
Protein Sub Type	Other\|RECEPTOR-ANTAGONIST
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	9013DUQ28K
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

ANAKINRA

Official Name

English

Anakinra [WHO-DD]

Common Name

English

ANAKINRA [USAN]

Common Name

English

N(SUP 2)-L-METHIONYLINTERLEUKIN 1 RECEPTOR ANTAGONIST (HUMAN ISOFORM X REDUCED)

Common Name

English

ANAKINRA [MART.]

Common Name

English

Showing 1 to 5 of 18 entries

Previous1 2 3 4Next

Show entries

Classification Tree

Code System

Code

Interleukin inhibitors

WHO-ATC

L04AC03

Designated

FDA ORPHAN DRUG

65892

Established Pharmacologic Class

NDF-RT

N0000175710

Designated

FDA ORPHAN DRUG

59991

Designated

FDA ORPHAN DRUG

636118

Showing 1 to 5 of 14 entries

Previous1 2 3Next

Show entries

Code System

Code

Type

Description

EVMPD

SUB05500MIG

PRIMARY

ChEMBL

CHEMBL1201570

PRIMARY

PUBCHEM

90470007

PRIMARY

DRUG BANK

DB00026

PRIMARY

USAN

DD-88

PRIMARY

Showing 1 to 5 of 17 entries

Previous1 2 3 4Next

Subunit 0

Show entries

From	To
1_67	1_117

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Related Record

Type

Details


					0GE6RE839P

INTERLEUKIN-1 RECEPTOR TYPE 1

TARGET -> INHIBITOR

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Related Record

Type

Details


					9013DUQ28K

ANAKINRA

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Name	Property Type	Amount
Molecular Formula	CHEMICAL	ESTIMATED C759H1178N208O232S10
MOL_WEIGHT:SEQUENCE	CHEMICAL	SEQUENCE 17256.5 Da (average)
Biological Half-life	PHARMACOKINETIC	[4 to 6] hours (average)